• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Thioredoxin domain-containing protein 8 (TXNDC8)

ACP16988

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP16988 Target NameTXNDC8
Target SynonymsTXNDC8; SPTRX3; TRX6; Thioredoxin domain-containing protein 8; Spermatid-specific thioredoxin-3; Sptrx-3; Thioredoxin-6FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-127
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ6A555
Background Information
  • Uniprot Id

    Q6A555

  • Target Species

    Human

  • Target Name

    TXNDC8

  • Target Full Name

    Thioredoxin domain-containing protein 8

  • Target Function

    May be required for post-translational modifications of proteins required for acrosomal biogenesis. May act by reducing disulfide bonds within the sperm.

  • Target Subcellular Location

    Cytoplasm. Golgi apparatus.

  • Target Protein Families

    Thioredoxin family

  • Target Tissue Specificity

    Testis-specific. Only expressed during spermiogenesis, prominently in the Golgi apparatus of pachytene spermatocytes and round and elongated spermatids, with a transient localization in the developing acrosome of round spermatids (at protein level).

  • Target Synonyms

    TXNDC8; SPTRX3; TRX6; Thioredoxin domain-containing protein 8; Spermatid-specific thioredoxin-3; Sptrx-3; Thioredoxin-6

Inquire Recombinant Human Thioredoxin domain-containing protein 8 (TXNDC8) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification